Skip to main content
. 2020 Jan 24;2020(1):CD013226. doi: 10.1002/14651858.CD013226.pub2

Eftekhar 2016b.

Methods RCT
Single centre
Iran
Participants Women undergoing fresh IVF
Inclusion criteria:
  • Infertile women aged 18 to 40 years

  • Normal endometrial thickness


Exclusion criteria:
  • Women with RIF (failure to conceive following 2 embryo transfer cycles, or cumulative transfer of > 10 good‐quality embryos)

  • Endocrine disorders

  • Severe endometriosis

  • Congenital or acquired uterine anomaly (uterine polyp, submucosal myoma, intrauterine adhesions)

  • Contraindication for G‐CSF (renal disease, sickle cell disease, malignancy history, upper respiratory tract infection, pneumonia, or chronic neutropenia)

Interventions Intervention group (N = 55): 300 μg transcervical intrauterine of G‐CSF was administered at the oocyte retrieval day
Control group (N =58): no additional intervention
Outcomes Implantation rate, clinical pregnancy rate, ongoing pregnancy rate, miscarriage rate
Notes Registered trial (IRCT201508236420N13). We tried contacting the authors for clarification on study methods but did not receive a reply.